IP Library Granted Patent US 8,859,855
Granted Patent B2
US 8,859,855 · App. 13/633,770 · Granted Oct 14, 2014

Chimeric PUFA polyketide synthase systems and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,859,855
App. No.
13/633,770
Granted
Oct 14, 2014
Kind
B2
Abstract

Disclosed are chimeric polyunsaturated fatty acid (PUFA) olyketide synthase (PKS) proteins and chimeric PUFA PKS systems, including chimeric PUFA PKS proteins and systems derived from Schizochytrium and Thraustochytrium . Disclosed are nucleic acids and proteins encoding such chimeric PUFA PKS proteins and systems, genetically modified organisms comprising such chimeric PUFA PKS proteins and systems, and methods of making and using such chimeric PUFA PKS proteins and systems.

Claims (20)

1. An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a chimeric OrfC protein that is at least 95% identical to SEQ ID NO:74.

2. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence is at least 95% identical to SEQ ID NO:73.

3. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence is optimized for the codon usage of an organism in which the nucleic acid molecule is to be expressed.

4. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence is optimized for the codon usage of an organism from which a portion of the chimeric protein is derived.

5. The isolated nucleic acid molecule of claim 1 , wherein the nucleic acid sequence is at least 95% identical to SEQ ID NO:75.

6. A recombinant nucleic acid molecule comprising the nucleic acid molecule of claim 1 .

7. A recombinant host cell comprising the nucleic acid molecule of claim 1 .

8. The recombinant host cell of claim 7 , wherein the cell is a microorganism.

9. The recombinant host cell of claim 8 , wherein the microorganism is a Schizochytrium.

10. The recombinant host cell of claim 8 , wherein the microorganism is a bacterium.

11. The recombinant host cell of claim 8 , wherein the microorganism is a yeast.

12. The recombinant host cell of claim 7 , wherein the cell is a plant cell.

13. A genetically modified plant or part thereof, comprising the recombinant host cell of claim 12 .

14. A method to produce at least one polyunsaturated fatty acid (PUFA), comprising culturing or growing under conditions effective to produce the PUFA, a host cell that expresses a PKS system for production of PUFAs, wherein the host cell comprises the nucleic acid molecule of claim 1 .

15. The method of claim 14 , wherein the cell is a microorganism.

16. The method of claim 15 , wherein the microorganism is a Schizochytrium.

17. The method of claim 15 , wherein the microorganism is a bacterium.

18. The method of claim 15 , wherein the microorganism is a yeast.

19. The method of claim 14 , wherein the cell is a plant cell.

20. The method of claim 19 , wherein a genetically modified plant or part thereof comprises the plant cell.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2014
From: WEAVER, CRAIG A; ZIRKLE, ROSS; DOHERTY, DANIEL H; METZ, JAMES G
To: MARTEK BIOSCIENCES CORPORATION
Reel/Frame 033817/0634 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2014
From: MARTEK BIOSCIENCES CORPORATION
To: DSM IP ASSETS B.V.
Reel/Frame 033817/0701 →